Getting your Trinity Audio player ready...
LyphoMed Inc. and Vestar Inc. entered a joint venture to develop and market liposome formulations of selected drugs. Liposomes, an emerging injectable drug technology, can improve the efficacy of drugs. LyphoMed, based in Rosemont, is a supplier of injectable drugs. California-based Vestar specializes in liposome technology.
